D-1492-2020 Class II Terminated
FDA drug recall D-1492-2020 was initiated by Teva Pharmaceuticals USA on Jul 14, 2020 and is designated Class II. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp date on the individual transdermal pouches but not in the carton. The recall status is terminated (terminated Jul 7, 2021). Affected quantity: 28,596 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 19, 2020
- Initiation Date
- Jul 14, 2020
- Termination Date
- Jul 7, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 28,596 cartons
Product description
Lidocaine Patch 5%, packaged in 30-count cartons, Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA, NDC 0591-3525-30
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp date on the individual transdermal pouches but not in the carton.
Distribution pattern
Nationwide United States
Code information
Carton Lot # 1383513B, Patch Lot # 1383513, Exp date 03/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1492-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026